Blow The Man Down

Today's Events
Nothing to speak of!
Coming Up

Overheard
- Companies are monitoring and enforcing office attendance at the highest rate in 5 years
- Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
- Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
- Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop
- Eli Lilly’s weight-loss pill didn’t work so well, and the stock is tumbling